Cellectis

Developer of cancer immunotherapies based on gene-edited CAR T-cells

placeParis, Ile De France, France calendar_todayFounded 1999 groups236 employees language cellectis.com

Innovation

191 patent families (110 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing.

Social engagement

Social engagement: 48.7K social following, 9 posts in the last 12 months — below the industry typical range.

Hiring activity

Hires periodically

5 roles tracked across 4 of the last 12 months

10 Jun 2026 · Senior Manager, Facilities · Raleigh

10 Jun 2026 · Director, Quality Control · Raleigh

11 Oct 2025 · Director, Development Program Management · New York

11 Sep 2025 · Manager, CSV · Raleigh

29 Jul 2025 · Manufacturing Operations Associate II · Raleigh

Based on job postings tracked across public sources.

Recent activity

20 May 2026
Event
Celelectis Annual Shareholders General Meeting
13 May 2026
Event
ASGCT 2026
12 May 2026
Event
European Hematology Association (EHA) 2026 congress
Coming soon